Correlation Between Cumberland Pharmaceuticals and ENTERPRISE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and ENTERPRISE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and ENTERPRISE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and ENTERPRISE PRODUCTS OPERATING, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and ENTERPRISE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of ENTERPRISE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and ENTERPRISE.

Diversification Opportunities for Cumberland Pharmaceuticals and ENTERPRISE

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cumberland and ENTERPRISE is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and ENTERPRISE PRODUCTS OPERATING in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ENTERPRISE PRODUCTS and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with ENTERPRISE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ENTERPRISE PRODUCTS has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and ENTERPRISE go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and ENTERPRISE

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to under-perform the ENTERPRISE. But the stock apears to be less risky and, when comparing its historical volatility, Cumberland Pharmaceuticals is 12.76 times less risky than ENTERPRISE. The stock trades about -0.01 of its potential returns per unit of risk. The ENTERPRISE PRODUCTS OPERATING is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  7,788  in ENTERPRISE PRODUCTS OPERATING on August 30, 2024 and sell it today you would lose (417.00) from holding ENTERPRISE PRODUCTS OPERATING or give up 5.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy88.28%
ValuesDaily Returns

Cumberland Pharmaceuticals  vs.  ENTERPRISE PRODUCTS OPERATING

 Performance 
       Timeline  
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong forward indicators, Cumberland Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
ENTERPRISE PRODUCTS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ENTERPRISE PRODUCTS OPERATING has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ENTERPRISE is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cumberland Pharmaceuticals and ENTERPRISE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cumberland Pharmaceuticals and ENTERPRISE

The main advantage of trading using opposite Cumberland Pharmaceuticals and ENTERPRISE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, ENTERPRISE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ENTERPRISE will offset losses from the drop in ENTERPRISE's long position.
The idea behind Cumberland Pharmaceuticals and ENTERPRISE PRODUCTS OPERATING pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments